Spreadex Market Update

FTSE lifted by oil and pharmaceutical sectors, whilst US investors eye Fed meeting minutes




Tripping at the open the Dow Jones slipped by around 15 to 30 points this Wednesday, a lack of data and hesitation ahead of this evening’s Fed meeting minutes supressing the appetite of US investors. It will be interesting to see what is uncovered with the latest insight into the inner workings of the central bank. Reports of discord between a dovish Yellen and the FOMC’s more hawkish members have only grown in the past few weeks, and investors will likely be keen to see what kind of rhetoric was used by both sides in March’s meeting, especially if it helps provide an idea of when the balance might shift in favour of those supporting a rate hike.

The FTSE, meanwhile, managed to outperform the rest of the major global indices, just about maintaining the half a percent rise is saw at the very start of the European session thanks to two of its key sectors. Firstly Brent Crude’s $39 per barrel-pushing rebound helped to instil the semblance of stability in the oil stocks (even if their mining peers have been dragged down by a one month low-showing from copper). Secondly the likes of AstraZeneca and Shire saw unexpected growth as the day continued, the fallout from the failed Pfizer/Allergan merger causing many to speculate that the former might be go shopping again to satisfy its M&A-thirst.


DISCLAIMER


Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 64% of retail investors lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money. For professional clients, spread betting and CFD trading can also result in losses larger than your initial stake or deposit.

Spreadex Ltd is authorised and regulated by the Financial Conduct Authority, provides an execution only service and does not provide advice in any way. Nothing within this update should be deemed to constitute the provision of investment advice, recommendations, any other professional advice in any way, or a record of our trading prices. This update does not constitute or form part of an offer of, or solicitation for a transaction in any financial instrument, nor shall it or the fact of its distribution form the basis of, or be relied on in connection with, any contract therefore. Any persons placing trades based on their interpretation of the comments or information within this update does so entirely at their own risk.

No representation, warranty, or undertaking, express or limited, is given as to the accuracy or completeness of the information or opinions contained within this update by Spreadex Ltd or any of its employees and no liability is accepted by such persons for the accuracy or completeness of any such information or opinions. As such, no reliance may be placed for any purpose on the information and opinions contained within this update.

The information contained within this update is the intellectual property of Spreadex Ltd and is protected by UK and International copyright laws. All rights reserved. Users may however freely download, distribute and reproduce extracts of the contents, subject always to accrediting Spreadex Ltd as the source and providing a hyperlink to www.spreadex.com.